Circulating Tumor Cell Diagnostics Market

Circulatingtumorcells(CTCs)arecellsthathaveshed intothevasculatureorlymphaticsfrom a primarytumorand arecarried around thebodyintheblood circulation.

Circulating Tumor Cell Diagnostics Market contains market size and forecasts of Circulating Tumor Cell (CTC) Diagnostics in Global, including the following market information:

Global Circulating Tumor Cell (CTC) Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Circulating Tumor Cell (CTC) Diagnostics market was valued at 7608.8 million in 2021 and is projected to reach US$ 19620 million by 2028, at a CAGR of 14.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

CTC Enrichment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Circulating Tumor Cell (CTC) Diagnostics include ApoCell, Inc.(US), Biocep Ltd. (Israel), Biocept, Inc.(US), Biofluidica MicrotechnologiesLLc(US), Celltraffix Inc.(US), ClearbridgeBiomedics(Singapore), Creatv Microtech, Inc.(US), CynvenioBiosystems, Inc.(US) and EpicBiosciencesInc.(US), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Wesurveyed the Circulating Tumor Cell (CTC) Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Circulating Tumor Cell (CTC) Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Circulating Tumor Cell (CTC) Diagnostics Market Segment Percentages, by Type, 2021 (%)

CTC Enrichment

CTC Detection

Global Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Circulating Tumor Cell (CTC) Diagnostics Market Segment Percentages, by Application, 2021 (%)

Hospitals and clinics

Pharmaceuticals and biotechnology companies

Academic research institutes

CROs

Global Circulating Tumor Cell (CTC) Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Circulating Tumor Cell (CTC) Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Circulating Tumor Cell (CTC) Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Circulating Tumor Cell (CTC) Diagnostics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

ApoCell, Inc.(US)

Biocep Ltd. (Israel)

Biocept, Inc.(US)

Biofluidica MicrotechnologiesLLc(US)

Celltraffix Inc.(US)

ClearbridgeBiomedics(Singapore)

Creatv Microtech, Inc.(US)

CynvenioBiosystems, Inc.(US)

EpicBiosciencesInc.(US)

FluxionBiosciences, Inc.(US)

Ikonisys, Inc.(US)

IVDiagnostics, Inc.(US)

JanssenDiagnosticsLLc(US)

QIAGEnHannoverGmbH (Germany)

RARECELLsSAs(Italy)

ScreenCell(France)

STEMCELlTechnologies, Inc.(Canada)